palonosetron hydrochloride

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 135729-62-3

Where It Comes From

29 FDA-registered drug labelers
Apotex Corp.
Aurobindo Pharma Limited
Avenacy, Inc.
Avyxa Pharma, LLC
Baxter Healthcare Corporation
BluePoint Laboratories
Catalent Pharma Solutions, LLC
Cipla Ltd.
Cipla USA Inc.
Dr.Reddy's Laboratories Limited
Emcure Pharmaceuticals Limited
Eugia US LLC
Fresenius Kabi USA, LLC
HAS Healthcare Advanced Synthesis SA
Helsinn Therapeutics (U.S.), Inc.
Meitheal Pharmaceuticals Inc.
MSN Laboratories Private Limited
Mylan Institutional LLC
NorthStar Rx LLC
Qilu Pharmaceutical Co. Ltd.
Rolabo Outsourcing S.L.
Sagent Pharmaceuticals
Sandoz Inc
TAPI Czech Industries s.r.o.
Teva Czech Industries s.r.o
Teva Parenteral Medicines, Inc.
TYCHE INDUSTRIES LIMITED
USV Private Limited
Wavelength Enterprises LTD

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • Palonosetron
  • posfrea
  • Palonosetron Hydrochloride
  • Akynzeo
FDA Shortage Status
No Shortage
Shortage History
to be discontinued

Palonosetron Hydrochloride Injection

11/14/2025

Chemical Identity

CAS135729-62-3
PubChem CID6918303
DTXSIDDTXSID8046610
FormulaC19H25ClN2O
Mol. Weight332.9 g/mol
SMILESC1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5.Cl

Data Sources

69183032026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/palonosetron hydrochloride/cids/JSON

Archive: data/sources/pubchem_name/palonosetron hydrochloride.json

CAS 135729-62-32026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 135729-62-32026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json